文献速递肾移植慢性肾脏病

肾移植前后终末期肾病患者药物负担与用药方案复杂性的变化评估

Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation.
PubMed 文献 · Kidney Int Rep · 2020-10-17

本研究回顾性分析354例成人肾移植患者,在移植前、移植出院时(M0)、术后4个月(M4)和12个月(M12)四个时间点评估处方药物负担和用药方案复杂性指数(MRCI)。结果显示移植后各时间点的药片负担和MRCI均显著高于移植前(P < 0.001),且糖尿病和血脂异常与M12时MRCI升高独立相关。

要点

  • 肾移植后各时间点药物负担和MRCI均显著高于移植前。
  • 移植前、M0、M4、M12服用≥10种药物的患者比例分别为21%、42%、53%、38%。
  • 糖尿病和血脂异常与M12时MRCI升高独立相关。

核心结论

  • 肾移植受者移植后各时间点的药物负担和MRCI均高于移植前。
  • 药物负担和MRC对服药依从性和临床结局的影响需进一步评估。

研究设计与样本

  • 回顾性研究,纳入354例接受肾移植的成人患者。
  • 从病历中提取移植前、M0、M4、M12四个时间点的处方药物数量、类型、药片负担和MRCI。
  • 采用逻辑回归模型识别M12时MRCI升高的相关因素。

主要发现

  • 354例患者的中位年龄为52岁(四分位距42-62)。
  • 移植前、M0、M4、M12服用10种及以上药物的患者比例分别为21%、42%、53%、38%。
  • M12时最常处方的三类药物为免疫抑制剂、心血管系统药物和作用于消化道及代谢的药物。
  • 移植前药片负担和MRCI显著低于移植后各时间点(P < 0.001)。
  • 糖尿病和血脂异常与M12时MRCI升高独立相关。

临床怎么用

  • 肾移植后需关注药物负担和方案复杂性增加,尤其合并糖尿病或血脂异常者。
  • 移植后用药管理应定期评估药物负担和MRCI,以优化处方。

局限性

  • 本研究为回顾性设计。
  • 药物负担和MRC对服药依从性及临床结局的影响尚未评估,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Medication regimen complexity (MRC) has not been characterized in detail in patients with end-stage renal disease (ESRD). The objective of the present study was to quantify changes over time in the prescription drug burden and MRC in patients with ESRD (before transplantation, on discharge after kidney transplantation [M0], and 4 months [M4] and 12 months [M12] afterward). METHODS: We retrospectively studied adult patients having undergone kidney transplantation. The number and types of drug prescribed, the pill burden, and the MRC index (MRCI) at 4 different time points (before transplantation, M0, M4, and M12) were extracted from the patients' medical records. MRCI was calculated by adding each drug score (calculated according to its formulation, dosing frequency, and additional instructions concerning administration). Hence, the MRCI took account of all prescription drugs. A logistic regression model was used to identify factors associated with an elevated MRCI at M12. RESULTS: The median (interquartile range) age of the 354 study participants was 52 years (42-62). Respectively 21%, 42%, 53%, and 38% of the patients were taking 10 or more drugs before transplantation and at M0, M4, and M12. At M12, the 3 most frequently prescribed drug classes were immunosuppressants, cardiovascular system drugs, and drugs acting on the alimentary tract and metabolism. The pill burden and MRCI before transplantation were significantly lower (P < 0.001) than at each time point after transplantation. Diabetes and dyslipidemia were independently associated with an elevated MRCI at M12. CONCLUSION: In kidney transplant recipients, the drug burden and MRCI were greater at all time points after transplantation than before transplantation. The impact of the drug burden and MRC on medication adherence and clinical outcomes in these patients requires further evaluation.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Marienne J, Laville SM, Caillard P, et al. Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation. Kidney Int Rep. 2020. PMID: 33426392. doi:10.1016/j.ekir.2020.10.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。